Shuttle Pharma Drops After Dogecoin Move Gets First Look From Investors
Shuttle Pharmaceuticals shares fell 3.2% to $0.507 after the company shifted from cancer-drug development to mining Dogecoin and Litecoin. The firm completed its merger with United Dogecoin and announced a $9.55 million private placement. Shuttle reported no revenue and a $2.2 million net loss for the last quarter, with a working-capital deficit near $5.8 million. Crypto mining stocks and Dogecoin also declined.